Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Paolo Maggi and Antonio Di Biagio.
Paolo Maggi
Connection Strength
1.565
Antonio Di Biagio
  1. Factors associated with hospital admission for COVID-19 in HIV patients. AIDS. 2020 11 01; 34(13):1983-1985.
    View in: PubMed
    Score: 0.228
  2. SLAM Project - Second-Level Diagnostic Assessment: Multidisciplinary approach to HIV Patients. New Microbiol. 2019 Jul; 42(3):150-155.
    View in: PubMed
    Score: 0.208
  3. Clusterization of co-morbidities and multi-morbidities among persons living with HIV: a cross-sectional study. BMC Infect Dis. 2019 Jun 25; 19(1):555.
    View in: PubMed
    Score: 0.207
  4. A Comprehensive Development Agenda on Tenofovir Alafenamide in Clinical Practice. AIDS Rev. 2018 Apr-Jun; 20(2):75-82.
    View in: PubMed
    Score: 0.190
  5. Use of quantitative ultrasound as bone mineral density evaluation in an Italian female population living with HIV: A real-life experience. J Women Aging. 2019 Mar-Apr; 31(2):176-188.
    View in: PubMed
    Score: 0.188
  6. Cardiovascular risk and dyslipidemia among persons living with HIV: a review. BMC Infect Dis. 2017 08 09; 17(1):551.
    View in: PubMed
    Score: 0.182
  7. Use of statins and aspirin to prevent cardiovascular disease among HIV-positive patients. A survey among Italian HIV physicians. New Microbiol. 2017 Apr; 40(2):139-142.
    View in: PubMed
    Score: 0.175
  8. Improvement of lipid profile after switching from efavirenz or ritonavir-boosted protease inhibitors to rilpivirine or once-daily integrase inhibitors: results from a large observational cohort study (SCOLTA). BMC Infect Dis. 2018 07 31; 18(1):357.
    View in: PubMed
    Score: 0.049
  9. Durability, safety, and efficacy of rilpivirine in clinical practice: results from the SCOLTA Project. Infect Drug Resist. 2018; 11:615-623.
    View in: PubMed
    Score: 0.048
  10. Safety and tolerability of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil fumarate in a real life setting: Data from surveillance cohort long-term toxicity antiretrovirals/antivirals (SCOLTA) project. PLoS One. 2017; 12(6):e0179254.
    View in: PubMed
    Score: 0.045
  11. Co-administration of tenofovir plus protease inhibitor based antiretroviral therapy during sofosbuvir/ledipasvir treatment for HCV infection: Much Ado About Nothing? Clin Res Hepatol Gastroenterol. 2017 10; 41(5):e76-e79.
    View in: PubMed
    Score: 0.045
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.